Security key
088786108
BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (BCYC)
CUSIP: 088786108
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share
- Shares outstanding
- 50,340,741
- Total 13F shares
- 37,459,664
- Share change
- -1,713,415
- Total reported value
- $173,586,582
- Put/Call ratio
- 1133%
- Reported price per share
- $4.64
- Number of holders
- 97
- Value change
- -$22,803,169
- Number of buys
- 58
- Number of sells
- 41
Security identity
Holder snapshot
Report period
Q1 2026
Institutions
97
Top holders
10
BCYC full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
BICYCLE THERAPEUTICS PLC SEC filings
BICYCLE THERAPEUTICS PLC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 088786108
Recent filing periods:
Ownership snapshot
Top reported holders of BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Forbion Growth Opportunit...
13D/G signal
Forbion Growth Opportunit...
Evidence rows
15
Latest as of
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.3%
13D/G row: Forbion Growth Opportunities Fund II Cooperatief U.A.
Showing 1-6 of 15 holder rows.
Rank 1 holder
Forbion Growth Opportunities Fund II Cooperatief U.A.
13D/G
- Ownership
- 7.3%
- Position
- $28.34M
Rank 2 holder
ARMISTICE CAPITAL, LLC
13F
13D/G
- Ownership
- 6.8%
- Position
- $22.91M
Rank 3 holder
Long Focus Capital Management, LLC
13D/G
13F
- Ownership
- 6.6%
- Position
- $16.49M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Forbion Growth Opportunities Fund II Cooperatief U.A. |
13D/G
|
7.3%
|
$28,343,629
3,452,330 shares
|
$0 | 21 Nov 2024 |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
6.8%
from 13D/G
|
$22,910,880
3,236,000 shares
|
— | 31 Dec 2025 |
| Long Focus Capital Management, LLC |
13D/G
13F
Company
|
6.6%
|
$16,487,221
3,310,687 shares
|
$0 | 31 Mar 2026 |
| Point72 Asset Management, L.P. |
13D/G
13F
Company
|
3.9%
|
$14,882,536
1,860,317 shares
|
-$15,032,008 | 30 Jun 2025 |
| Invus Global Management, LLC |
13D/G
Raymond Debbane
|
3.1%
|
$7,773,192
1,560,882 shares
|
-$7,909,072 | 31 Mar 2026 |
| Deep Track Capital, LP |
13D/G
|
2.4%
|
$9,625,952
1,203,244 shares
|
-$12,943,416 | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
97
Shares
37,459,664
Rows available
97
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
108
Q1 2026 holders
97
Holder diff
-11
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend